The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the workforce-talent pipeline.

The new research and development site will combine research, process development and clinical trial manufacturing capabilities into one plant.

The LillyDirect website connects people with independent telehealth providers, tailored support and other disease management resources. The website also allows patients to have some medications delivered directly to their home.

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.

The ‘Lilly Scholars @ Ivy Tech' program will build on Ivy Tech’s existing biopharmaceutical manufacturing certification program. Eli Lilly will fund the $15 million project for the next five years.

The Indianapolis-based pharmaceutical company, Eli Lilly and Company, announced Wednesday it will lower the prices of its branded insulin by 70 percent and will introduce more price caps for its non-branded insulin.

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions.

Eli Lilly shares slipped Friday after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment.

Efforts are underway to build a massive, multi-billion dollar research and industrial park near Lebanon, Indiana. But as the project has grown, questions are being raised by both residents and the leaders of neighboring cities about what the project will look like - and what kind of resources it will require.

T1International, an advocacy group for type 1 diabetics, is calling on pharmaceutical companies like Eli Lilly to lower their insulin prices. The group has been pushing these efforts in Indianapolis for several years.